Hainan Haiyao Co., Ltd. (SHE:000566)

Market Cap	8.06B +36.2%
Revenue (ttm)	825.66M -19.9%
Net Income	-1.47B
EPS	-1.14
Shares Out	1.30B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,257,739
Average Volume	93,942,535
Open	6.38
Previous Close	6.21
Day's Range	6.15 - 6.38
52-Week Range	3.76 - 9.24
Beta	0.52
RSI	37.80
Earnings Date	Apr 11, 2026

About Hainan Haiyao

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective products, breathing products, anti-tumor products, chronic disease category products, vitamins, Chinese herbal medicine slices, and medical services. Hainan H...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 2,003
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000566

Financial Performance

In 2024, Hainan Haiyao's revenue was 990.70 million, a decrease of -33.00% compared to the previous year's 1.48 billion. Losses were -1.53 billion, 1332.3% more than in 2023.